首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical cancer research

缩写:CLIN CANCER RES

ISSN:1078-0432

e-ISSN:1557-3265

IF/分区:10.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11950条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Helen M R Robinson,Vera Grinkevich,Jayesh B Majithiya et al. Helen M R Robinson et al.
DNA polymerase theta (Polθ ) is the central component of the DNA double strand break repair process of microhomology mediated end-joining (MMEJ). Targeting Polθ for cancer therapy has been proposed due to its tumour-selective expression, ...
Filippo G Dall&#x;Olio,Wael Zrafi,Damien Vasseur et al. Filippo G Dall&#x;Olio et al.
Background: Immune checkpoint blockers (ICBs) have transformed advanced non-small cell lung cancer (aNSCLC) treatment, but identifying patients who benefit from adding chemotherapy remains challenging, especially in PD-L1...
Adrienne G Waks,Elia Segui,Tianyu Li et al. Adrienne G Waks et al.
Purpose: The efficacy of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) in hormone receptor-positive/HER2-negative metastatic breast cancer is limited by resistance mechanisms, including mitogen-activated protein ki...
Minjiang Chen,Rongzhen Li,Zuolin Cheng et al. Minjiang Chen et al.
Background: Neoadjuvant chemoimmunotherapy improves outcomes in resectable non-small cell lung cancer (NSCLC), yet the spatial immune features associated with treatment response remain unclear. ...
Cinta Hierro,Mònica Sánchez-Guixé,Gabi Tarcic et al. Cinta Hierro et al.
Purpose: The predictive value of FGFR amplifications (amp) and the role of FGFR mutations (mut) beyond known activating variants remain unclear. We aimed to establish a translational research platform to characterize FGFR...
Sarah B Goldberg,Myung-Ju Ahn,Christina Baik et al. Sarah B Goldberg et al.
Purpose: ORCHARD (NCT03944772) was a phase II, open-label study evaluating resistance mechanisms and post-progression therapies in patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung...
Adam J Webb,Emily Harper,Tim Rattay et al. Adam J Webb et al.
Purpose: We showed previously that breast cancer patients with certain circadian rhythm genotypes have higher incidences of toxicity when treated with radiotherapy at different times of day. This opens the way to genetica...
Julie Nonnekens,Lauren A Byers,Aman Chauhan et al. Julie Nonnekens et al.
Targeted radionuclide therapy (TRT) is an emerging modality in oncology that delivers internal radiation specifically to tumor sites. It typically consists of a particle-emitting radionuclide, a linking complex with a chelator for securely ...
Komal Gupta,Daniel S W Tan,Regina Hoo Komal Gupta
A recent article presents the largest histo-genomic characterisation of first-line osimertinib resistance from ORCHARD study. Dual-modality tissue and plasma sequencing detected resistance alterations in 87% and polyclonal mechanisms in 46%...